La diagnosi e la terapia delle pneumopatie infiltrative da farmaci

Translated title of the contribution: Diagnosis and therapy of drug-induced interstitial lung diseases

G. Brunetti, A. Rossi, L. Manzo

Research output: Contribution to journalArticle

Abstract

Drug-induced interstitial lung diseases (DI-ILD) are the most common clinical pattern of iatrogenic pathology of the respiratory tract. The prevalence of DI-ILD in Italy has been estimated at 1.7% (from data in the Italian Register of Interstitial Lung Diseases). The pathogenesis can be immunologic, due to changes in homeostatic systems (oxidants/ antioxidants, proteases/antiproteases), or to changes in collagen balance or to intracellular drug accumulation with changes in enzyme systems. Major risk factors are age, cumulative drug dosage, underlying disease, and even earlier radiotherapy and oxygen treatment. Diagnosis is based on the temporal relationship between beginning of drug treatment and onset of respiratory symptoms, so that clinical and drug history is the most important diagnostic approach. Only in a few cases can traditional diagnostic tools, such as high-resolution computed tomography (HRCT), bronchoalveolar lavage (BAL) and histology) provide characteristic findings to point to a correct diagnosis. Treatment is the immediate withdrawal of the drug followed by steroid therapy.

Original languageItalian
Pages (from-to)156-168
Number of pages13
JournalRassegna di Patologia dell'Apparato Respiratorio
Volume21
Issue number3
Publication statusPublished - Jun 2006

Fingerprint

Interstitial Lung Diseases
Drug Therapy
Pharmaceutical Preparations
Bronchoalveolar Lavage
Therapeutics
Protease Inhibitors
Oxidants
Respiratory System
Italy
Histology
Peptide Hydrolases
Collagen
Radiotherapy
Antioxidants
History
Steroids
Tomography
Pathology
Oxygen
Enzymes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Pulmonary and Respiratory Medicine

Cite this

La diagnosi e la terapia delle pneumopatie infiltrative da farmaci. / Brunetti, G.; Rossi, A.; Manzo, L.

In: Rassegna di Patologia dell'Apparato Respiratorio, Vol. 21, No. 3, 06.2006, p. 156-168.

Research output: Contribution to journalArticle

Brunetti, G. ; Rossi, A. ; Manzo, L. / La diagnosi e la terapia delle pneumopatie infiltrative da farmaci. In: Rassegna di Patologia dell'Apparato Respiratorio. 2006 ; Vol. 21, No. 3. pp. 156-168.
@article{36965b46c37843f2bf33de801a03a490,
title = "La diagnosi e la terapia delle pneumopatie infiltrative da farmaci",
abstract = "Drug-induced interstitial lung diseases (DI-ILD) are the most common clinical pattern of iatrogenic pathology of the respiratory tract. The prevalence of DI-ILD in Italy has been estimated at 1.7{\%} (from data in the Italian Register of Interstitial Lung Diseases). The pathogenesis can be immunologic, due to changes in homeostatic systems (oxidants/ antioxidants, proteases/antiproteases), or to changes in collagen balance or to intracellular drug accumulation with changes in enzyme systems. Major risk factors are age, cumulative drug dosage, underlying disease, and even earlier radiotherapy and oxygen treatment. Diagnosis is based on the temporal relationship between beginning of drug treatment and onset of respiratory symptoms, so that clinical and drug history is the most important diagnostic approach. Only in a few cases can traditional diagnostic tools, such as high-resolution computed tomography (HRCT), bronchoalveolar lavage (BAL) and histology) provide characteristic findings to point to a correct diagnosis. Treatment is the immediate withdrawal of the drug followed by steroid therapy.",
keywords = "Drug induced lung disease, Interstitial lung disease, Pneumotoxicity",
author = "G. Brunetti and A. Rossi and L. Manzo",
year = "2006",
month = "6",
language = "Italian",
volume = "21",
pages = "156--168",
journal = "Rassegna di Patologia dell'Apparato Respiratorio",
issn = "0033-9563",
publisher = "EdiAipo Scientifica s.c.a.r.l",
number = "3",

}

TY - JOUR

T1 - La diagnosi e la terapia delle pneumopatie infiltrative da farmaci

AU - Brunetti, G.

AU - Rossi, A.

AU - Manzo, L.

PY - 2006/6

Y1 - 2006/6

N2 - Drug-induced interstitial lung diseases (DI-ILD) are the most common clinical pattern of iatrogenic pathology of the respiratory tract. The prevalence of DI-ILD in Italy has been estimated at 1.7% (from data in the Italian Register of Interstitial Lung Diseases). The pathogenesis can be immunologic, due to changes in homeostatic systems (oxidants/ antioxidants, proteases/antiproteases), or to changes in collagen balance or to intracellular drug accumulation with changes in enzyme systems. Major risk factors are age, cumulative drug dosage, underlying disease, and even earlier radiotherapy and oxygen treatment. Diagnosis is based on the temporal relationship between beginning of drug treatment and onset of respiratory symptoms, so that clinical and drug history is the most important diagnostic approach. Only in a few cases can traditional diagnostic tools, such as high-resolution computed tomography (HRCT), bronchoalveolar lavage (BAL) and histology) provide characteristic findings to point to a correct diagnosis. Treatment is the immediate withdrawal of the drug followed by steroid therapy.

AB - Drug-induced interstitial lung diseases (DI-ILD) are the most common clinical pattern of iatrogenic pathology of the respiratory tract. The prevalence of DI-ILD in Italy has been estimated at 1.7% (from data in the Italian Register of Interstitial Lung Diseases). The pathogenesis can be immunologic, due to changes in homeostatic systems (oxidants/ antioxidants, proteases/antiproteases), or to changes in collagen balance or to intracellular drug accumulation with changes in enzyme systems. Major risk factors are age, cumulative drug dosage, underlying disease, and even earlier radiotherapy and oxygen treatment. Diagnosis is based on the temporal relationship between beginning of drug treatment and onset of respiratory symptoms, so that clinical and drug history is the most important diagnostic approach. Only in a few cases can traditional diagnostic tools, such as high-resolution computed tomography (HRCT), bronchoalveolar lavage (BAL) and histology) provide characteristic findings to point to a correct diagnosis. Treatment is the immediate withdrawal of the drug followed by steroid therapy.

KW - Drug induced lung disease

KW - Interstitial lung disease

KW - Pneumotoxicity

UR - http://www.scopus.com/inward/record.url?scp=33846707582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846707582&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:33846707582

VL - 21

SP - 156

EP - 168

JO - Rassegna di Patologia dell'Apparato Respiratorio

JF - Rassegna di Patologia dell'Apparato Respiratorio

SN - 0033-9563

IS - 3

ER -